Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone for Prevention of Stimulant-Induced Euphoria in ADHD
NCT01673594Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2012
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in stimulant-induced euphoria, sponsored by Massachusetts General Hospital. Started Sep 2012; status: completed.
02
Drugs
naltrexone
03
Conditions
stimulant-induced euphoria
Beyond the preview
Go deeper on NCT01673594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01673594.